As of Jun 24
| -1.28 / -1.14%|
The 5 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 108.00, with a high estimate of 118.00 and a low estimate of 102.00. The median estimate represents a -3.10% decrease from the last price of 111.46.
The current consensus among 6 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.